Universal Health Services, Inc. (UHS) Income Statement Analysis

See more : Vonovia SE (VONOY) Income Statement Analysis – Financial Results

Complete financial analysis of Universal Health Services, Inc. (UHS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Universal Health Services, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.

You may be interested

Lakeshore Acquisition II Corp. (LBBB) Income Statement Analysis – Financial Results
Tomoe Engineering Co., Ltd. (6309.T) Income Statement Analysis – Financial Results
LyondellBasell Industries N.V. (0EDD.L) Income Statement Analysis – Financial Results
Soitec S.A. (SLOIF) Income Statement Analysis – Financial Results
Pro Fin Capital Services Ltd. (PROFINC.BO) Income Statement Analysis – Financial Results

Universal Health Services, Inc. (UHS)

Industry: Medical - Care Facilities

Sector: Healthcare

Website: https://uhs.com

About Universal Health Services, Inc.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987	1986	1985
Revenue	14.28B	13.40B	12.64B	11.56B	11.38B	10.77B	10.41B	9.77B	9.04B	8.07B	7.28B	6.96B	7.50B	5.57B	5.20B	5.02B	4.75B	4.19B	3.94B	3.94B	3.64B	3.26B	2.84B	2.24B	2.04B	1.87B	1.44B	1.19B	931.10M	782.20M	761.50M	731.20M	690.90M	627.10M	587.20M	554.00M	775.00M	666.80M	505.80M
Cost of Revenue	8.64B	1.47B	1.43B	1.29B	1.25B	1.17B	1.11B	1.03B	974.09M	895.69M	821.09M	799.62M	4.22B	3.16B	2.90B	694.48M	2.72B	2.35B	2.12B	2.15B	1.34B	1.21B	1.04B	816.75M	828.80M	752.70M	575.10M	458.10M	361.00M	298.10M	643.90M	595.90M	583.40M	538.00M	508.50M	471.60M	420.30M	367.10M	285.80M
Gross Profit	5.64B	11.93B	11.21B	10.27B	10.13B	9.60B	9.30B	8.73B	8.07B	7.17B	6.46B	6.16B	3.28B	2.41B	2.30B	4.33B	2.04B	1.84B	1.82B	1.78B	2.30B	2.05B	1.80B	1.43B	1.21B	1.12B	867.60M	732.10M	570.10M	484.10M	117.60M	135.30M	107.50M	89.10M	78.70M	82.40M	354.70M	299.70M	220.00M
Gross Profit Ratio	39.50%	89.00%	88.71%	88.86%	89.00%	89.15%	89.38%	89.44%	89.23%	88.89%	88.73%	88.51%	43.78%	43.32%	44.19%	86.17%	42.85%	43.83%	46.23%	45.31%	63.10%	62.79%	63.52%	63.58%	59.42%	59.85%	60.14%	61.51%	61.23%	61.89%	15.44%	18.50%	15.56%	14.21%	13.40%	14.87%	45.77%	44.95%	43.50%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	7.25B	6.89B	6.28B	5.73B	5.70B	5.36B	5.08B	4.68B	4.31B	3.94B	3.70B	3.54B	91.77M	130.18M	69.95M	2.20B	0.00	0.00	0.00	0.00	0.00	0.00	1.42B	1.12B	944.00M	857.10M	661.60M	554.90M	442.90M	388.50M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	7.25B	6.89B	6.28B	5.73B	5.70B	5.36B	5.08B	4.68B	4.31B	3.94B	3.70B	3.54B	91.77M	130.18M	69.95M	2.20B	1.48B	1.35B	1.35B	1.29B	1.79B	1.59B	1.42B	1.12B	944.00M	857.10M	661.60M	554.90M	442.90M	388.50M	34.30M	33.90M	34.50M	0.00	0.00	0.00	259.10M	192.80M	123.30M
Other Expenses	0.00	4.03B	3.57B	3.18B	3.21B	14.22M	2.94B	5.34M	15.82M	27.90M	61.02M	30.04M	2.29B	1.78B	1.71B	1.71B	183.28M	163.69M	155.48M	155.51M	144.47M	124.79M	127.52M	112.81M	108.30M	105.40M	80.70M	71.90M	51.40M	42.40M	39.60M	49.10M	35.00M	48.50M	39.70M	39.40M	38.50M	40.10M	28.80M
Operating Expenses	4.47B	10.92B	9.85B	8.91B	8.91B	8.43B	8.02B	7.46B	6.83B	6.10B	5.51B	5.22B	2.39B	1.91B	1.78B	4.61B	1.67B	1.51B	1.51B	1.45B	1.93B	1.72B	1.54B	1.23B	1.05B	962.50M	742.30M	626.80M	494.30M	430.90M	73.90M	83.00M	69.50M	48.50M	39.70M	39.40M	297.60M	232.90M	152.10M
Cost & Expenses	13.11B	12.40B	11.28B	10.20B	10.16B	9.60B	9.13B	8.49B	7.80B	6.99B	6.33B	6.02B	6.60B	5.06B	4.68B	4.61B	4.38B	3.87B	3.62B	3.60B	3.27B	2.93B	2.58B	2.04B	1.88B	1.72B	1.32B	1.08B	855.30M	729.00M	717.80M	678.90M	652.90M	586.50M	548.20M	511.00M	717.90M	600.00M	437.90M
Interest Income	572.00K	378.00K	1.60M	2.80M	469.00K	1.53M	81.00K	150.00K	279.00K	537.00K	5.75M	85.00K	164.00K	391.00K	0.00	864.00K	1.06M	1.78M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	207.25M	126.89M	83.67M	106.29M	162.73M	154.96M	145.17M	125.05M	113.49M	133.64M	110.92M	131.27M	200.79M	77.60M	45.81M	53.21M	95.55M	34.34M	32.93M	64.14M	38.23M	52.44M	103.56M	29.94M	43.80M	36.20M	19.40M	29.40M	22.80M	6.30M	8.60M	11.40M	7.30M	22.20M	24.90M	28.10M	43.40M	38.50M	24.40M
Depreciation & Amortization	568.04M	581.86M	533.21M	510.49M	490.39M	453.05M	447.77M	416.61M	398.62M	375.62M	337.36M	308.69M	295.86M	224.00M	204.70M	195.77M	183.28M	163.69M	163.71M	166.68M	144.47M	124.79M	127.52M	112.81M	108.30M	105.40M	80.70M	71.90M	51.40M	42.40M	39.60M	49.10M	35.00M	48.50M	39.70M	39.40M	38.50M	40.10M	28.80M
EBITDA	1.71B	1.64B	1.93B	1.87B	1.80B	1.65B	1.73B	1.70B	1.66B	1.48B	1.35B	1.23B	1.18B	724.13M	720.36M	604.72M	550.17M	655.07M	477.76M	501.44M	981.12M	454.31M	387.98M	310.29M	269.60M	264.70M	206.00M	176.20M	127.20M	95.60M	83.30M	101.40M	73.00M	89.10M	78.70M	82.40M	95.60M	106.90M	96.70M
EBITDA Ratio	12.00%	11.75%	15.11%	16.17%	15.11%	15.25%	16.60%	17.39%	18.33%	18.29%	18.35%	18.01%	15.91%	13.10%	13.94%	11.26%	11.66%	7.61%	14.26%	12.73%	13.84%	13.88%	15.38%	14.18%	13.46%	14.12%	14.28%	15.23%	14.91%	12.22%	10.94%	13.87%	10.51%	14.14%	13.35%	15.07%	14.09%	16.59%	19.24%
Operating Income	1.18B	1.00B	1.36B	1.36B	1.22B	1.18B	1.28B	1.28B	1.26B	1.06B	1.02B	942.58M	897.13M	505.70M	520.53M	410.22M	370.27M	323.27M	314.04M	334.76M	369.46M	329.51M	260.45M	197.48M	161.30M	159.30M	125.30M	105.30M	75.80M	53.20M	43.70M	52.30M	38.00M	40.60M	39.00M	43.00M	57.10M	66.80M	67.90M
Operating Income Ratio	8.23%	7.49%	10.78%	11.75%	10.69%	10.91%	12.30%	13.12%	13.93%	13.18%	13.94%	13.54%	11.96%	9.08%	10.01%	8.17%	7.79%	7.71%	7.98%	8.50%	10.14%	10.11%	9.17%	8.81%	7.90%	8.50%	8.69%	8.85%	8.14%	6.80%	5.74%	7.15%	5.50%	6.47%	6.64%	7.76%	7.37%	10.02%	13.42%
Total Other Income/Expenses	-234.96M	-137.30M	-69.78M	-106.27M	-149.57M	-140.74M	-145.17M	-125.05M	-113.49M	-133.64M	-146.13M	-178.92M	-200.79M	-77.60M	-45.81M	-53.21M	-95.00M	135.44M	-141.90M	-78.49M	-537.34M	-52.44M	-102.56M	-51.37M	-38.50M	-36.20M	-19.70M	-24.30M	-22.80M	-6.30M	-8.60M	-11.40M	-7.70M	-22.20M	-24.90M	-28.10M	-43.40M	-38.50M	-24.40M
Income Before Tax	940.43M	866.26M	1.29B	1.25B	1.07B	1.03B	1.14B	1.16B	1.15B	929.67M	869.33M	763.66M	696.34M	428.10M	474.72M	316.32M	275.07M	412.47M	172.14M	271.14M	317.70M	277.07M	157.90M	146.11M	122.80M	123.10M	105.90M	80.00M	53.00M	46.90M	35.10M	40.90M	30.30M	18.40M	14.10M	14.90M	13.70M	28.30M	43.50M
Income Before Tax Ratio	6.58%	6.46%	10.23%	10.83%	9.37%	9.60%	10.90%	11.84%	12.67%	11.53%	11.94%	10.97%	9.28%	7.69%	9.13%	6.30%	5.79%	9.84%	4.37%	6.88%	8.72%	8.50%	5.56%	6.52%	6.01%	6.57%	7.34%	6.72%	5.69%	6.00%	4.61%	5.59%	4.39%	2.93%	2.40%	2.69%	1.77%	4.24%	8.60%
Income Tax Expense	221.12M	209.28M	305.68M	299.29M	238.79M	236.64M	363.70M	409.19M	395.20M	324.67M	315.31M	274.62M	247.47M	152.30M	170.48M	123.38M	104.55M	152.88M	62.30M	101.14M	118.43M	101.71M	57.15M	52.75M	45.00M	43.50M	38.60M	29.30M	17.50M	18.20M	11.10M	20.90M	10.00M	6.80M	5.10M	8.50M	11.30M	17.10M	21.80M
Net Income	717.80M	675.61M	991.59M	943.95M	814.85M	779.71M	752.30M	702.41M	680.53M	545.34M	510.73M	443.45M	398.17M	230.18M	260.37M	199.38M	170.39M	259.46M	240.85M	169.49M	199.27M	175.36M	99.74M	93.36M	77.80M	79.60M	67.30M	50.70M	35.50M	28.70M	24.00M	20.00M	20.30M	11.60M	9.00M	6.40M	300.00K	11.20M	21.70M
Net Income Ratio	5.03%	5.04%	7.84%	8.17%	7.16%	7.24%	7.23%	7.19%	7.53%	6.76%	7.01%	6.37%	5.31%	4.13%	5.00%	3.97%	3.59%	6.19%	6.12%	4.30%	5.47%	5.38%	3.51%	4.16%	3.81%	4.25%	4.66%	4.26%	3.81%	3.67%	3.15%	2.74%	2.94%	1.85%	1.53%	1.16%	0.04%	1.68%	4.29%
EPS	10.35	9.23	11.99	11.10	9.16	8.36	7.86	7.22	6.89	5.52	5.21	4.57	4.09	2.37	2.65	1.97	1.60	2.38	2.17	1.47	1.73	1.47	0.84	0.78	0.62	0.62	0.52	0.42	0.32	0.26	0.22	0.18	0.18	0.11	0.08	0.06	0.00	0.08	0.16
EPS Diluted	10.23	9.14	11.82	11.03	9.13	8.32	7.81	7.14	6.76	5.42	5.14	4.53	4.04	2.34	2.64	1.97	1.59	2.28	2.00	1.38	1.60	1.37	0.80	0.75	0.61	0.60	0.51	0.41	0.32	0.25	0.22	0.18	0.18	0.11	0.08	0.06	0.00	0.08	0.16
Weighted Avg Shares Out	69.32M	73.12M	82.52M	85.06M	88.76M	93.28M	95.65M	97.21M	98.80M	98.83M	98.03M	96.82M	97.20M	96.79M	97.79M	101.22M	106.76M	109.11M	111.32M	115.31M	119.38M	119.46M	119.75M	120.44M	125.67M	130.04M	129.42M	120.00M	112.63M	114.35M	107.87M	111.11M	111.23M	110.48M	116.13M	116.36M	120.00M	140.00M	140.00M
Weighted Avg Shares Out (Dil)	70.13M	73.83M	83.69M	85.59M	89.04M	93.75M	96.33M	98.38M	100.69M	100.54M	99.36M	97.71M	98.54M	97.97M	98.28M	101.46M	107.14M	115.82M	125.29M	129.73M	130.18M	134.15M	134.44M	129.64M	127.96M	133.17M	132.61M	122.91M	112.63M	115.11M	111.63M	111.11M	111.23M	110.48M	116.13M	116.36M	120.00M	140.00M	140.00M

Can These 3 Hospital Stocks Beat Q2 Earnings Expectations?

July 23, 2024zacks.com

Rising patient volumes, admission and occupancy levels are expected to have benefited hospital players in the second quarter, partly offset by higher costs. THC, UHS and CYH will release earnings on Jul 24.

Will Universal Health Services (UHS) Beat Estimates Again in Its Next Earnings Report?

July 22, 2024zacks.com

Universal Health Services (UHS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Sell Alert: 2 REITs That Could Lead To Large Losses

July 22, 2024seekingalpha.com

Not all REITs are worth buying. Management and conflicts of interest are common issues. Here are 2 REITs that I ended up selling at a loss.

4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates

July 19, 2024zacks.com

Expanding aging population and the increasing demand for affordable health products are likely to have boosted the performance of healthcare stocks in Q2. CI, UHS, HCA & THC are potential outperformers.

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND

July 18, 2024prnewswire.com

KING OF PRUSSIA, Pa. , July 18, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.20 per share on September 17, 2024 to shareholders of record...

Will Patient Volumes Drive Universal Health's (UHS) Q2 Earnings?

July 18, 2024zacks.com

Universal Health's (UHS) Q2 performance is likely to gain from strong performances in its Acute Care Hospital Services and Behavioral Health Care Services segments.

Universal Health Services (UHS) Earnings Expected to Grow: Should You Buy?

July 17, 2024zacks.com

Universal Health Services (UHS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Value Investors Buy Universal Health Services (UHS) Stock?

July 17, 2024zacks.com

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...

Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term

July 12, 2024zacks.com

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.